Last price paid | 0.72 | |
Change | -7.69% [ -0.06 ] | |
Last traded volume | n.a. Unit | |
Cumulative volume | n.a. Unit | |
Date/time | 30.07.2024 17:20 |
Fixing | n.a. |
Settlement date | 13.03.2024 |
Last trading | n.a. |
Final fixing | n.a. |
Currency redemption | CHF |
Perf. since issue | -33.18% |
Year to date (YTD) | n.a. |
1 month | +16.13% |
3 months | -40.00% |
1 year | n.a. |
3 years | n.a. |
Issue price | 1.10 |
Underlying price on issue | 108.50 |
Premium | 0.00% |
Premium p.a. | n.a. |
Leverage | n.a. |
Implied volatility | n.a. |
ISIN | CH1305144540 |
Symbol | ISRVDZ |
Security | 130514454 |
Exchange | SIX Structured Products |
Currency | CHF |
Expiry | n.a. |
Underlying | Swiss Re N, CH0126881561 |
Underlying ISIN | CH0126881561 |
Funding level | 123.239300 |
Stop-loss level | 119.713000 |
Distance to stop-loss level | 10.18% |
Long/Short type | Short |
Subscription ratio | 20.00 |
Issuer | Zürcher Kantonalbank |
Exercise type | n.a. |
Minimum execution | n.a. |
Value day | 11.03.2024 |
Premium | 0.10% |
Premium p.a. | n.a. |
Leverage | 7.39 |
Moneyness | in-the-money |
Leverage | n.a. |
Delta | n.a. |
Intrinsic value | 14.589300 |
Break-even | n.a. |
SSPA value at risk | n.a. |
SSPA risk rating | n.a. |
SSPA derivative category | Leverage |
SSPA code | Mini future (2210) |
Name | Price |
---|---|
Partners Group Ho... | 1'190.00 |
ABB Ltd | 48.77 |
Givaudan | 4'296.00 |
Lonza Group | 585.60 |
SONOVA HLDG N | 269.20 |
Name | Price |
---|---|
Sika AG | 268.40 |
Swiss Re | 108.80 |
ROCHE GS | 285.30 |
NOVARTIS N | 98.42 |
UBS | 26.69 |